InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

INE Insider Trading

Insider Ownership Percentage: 20.41%
Insider Buying (Last 12 Months): C$205,566.31
Insider Selling (Last 12 Months): C$0.00

Innergex Renewable Energy Insider Trading History Chart

This chart shows the insider buying and selling history at Innergex Renewable Energy by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Innergex Renewable Energy Share Price & Price History

Current Price: C$7.97
Price Change: ▼ Price Decrease of -0.22 (-2.69%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for INE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Innergex Renewable Energy Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2024Daniel LafranceDirectorBuy1,000C$7.98C$7,976.50
3/13/2024Daniel LafranceDirectorBuy5,000C$8.35C$41,750.00
2/28/2024Richard GagnonDirectorBuy3,125C$8.13C$25,408.75
2/26/2024Jean TrudelSenior OfficerBuy13,000C$7.68C$99,840.00
11/13/2023Richard GagnonDirectorBuy3,320C$9.02C$29,947.06
8/17/2023Pascale TremblaySenior OfficerBuy50C$12.88C$644.00
5/12/2022Richard GagnonDirectorBuy1,520C$16.46C$25,019.205,170
11/25/2021Daniel LafranceDirectorBuy1,000C$19.21C$19,210.0038,000
5/14/2021Daniel LafranceDirectorBuy2,000C$18.73C$37,460.0037,000
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Innergex Renewable Energy (TSE:INE)

40.76% of Innergex Renewable Energy stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Innergex Renewable Energy logo
Innergex Renewable Energy Inc. operates as an independent renewable power producer in Canada, the United States, France, and Chile. It acquires, owns, develops, and operates renewable power-generating and energy storage facilities primarily in hydroelectric, wind, and solar power sectors. The company operates through three segments: Hydroelectric Power Generation, Wind Power Generation, and Solar Power Generation. As of February 21, 2024, it owned and operated 87 facilities with a net installed capacity of 3,600 megawatts, including 41 hydroelectric facilities, 35 wind facilities, 9 solar facilities, and 2 battery energy storage facilities. The company is headquartered in Longueuil, Canada.
Read More on Innergex Renewable Energy

Today's Range

Now: C$7.97
Low: C$7.91
High: C$8.18

50 Day Range

MA: C$8.04
Low: C$7.13
High: C$8.69

52 Week Range

Now: C$7.97
Low: C$7.05
High: C$14.40

Volume

675,432 shs

Average Volume

786,013 shs

Market Capitalization

C$1.63 billion

P/E Ratio

N/A

Dividend Yield

4.55%

Beta

0.35

Who are the company insiders with the largest holdings of Innergex Renewable Energy?

Innergex Renewable Energy's top insider shareholders include:
  1. Richard Gagnon (Director)
  2. Daniel Lafrance (Director)
  3. Jean Trudel (Senior Officer)
  4. Pascale Tremblay (Senior Officer)
Learn More about top insider investors at Innergex Renewable Energy.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...